{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:13:21Z","timestamp":1790018001972,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006371","name":"Iberoamerican University Postgraduate Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"CIBERINFEC","doi-asserted-by":"publisher","award":["CB21\/13\/00044"],"award-info":[{"award-number":["CB21\/13\/00044"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["CIBERINFEC CB21\/13\/00044"],"award-info":[{"award-number":["CIBERINFEC CB21\/13\/00044"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017 N\\u00BA713"],"award-info":[{"award-number":["PICT 2017 N\\u00BA713"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2021 GRF TI 304"],"award-info":[{"award-number":["PICT 2021 GRF TI 304"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16CIII\/0002\/0002"],"award-info":[{"award-number":["RD16CIII\/0002\/0002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18CIII\/00020"],"award-info":[{"award-number":["PI18CIII\/00020"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2021-2023"],"award-info":[{"award-number":["PIP 2021-2023"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013101","name":"National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ncrna.2025.03.004","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:18:53Z","timestamp":1741144733000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study"],"prefix":"10.1016","volume":"12","author":[{"given":"Victoria","family":"Cairoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5205-855X","authenticated-orcid":false,"given":"Daniel","family":"Valle-Millares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-9026","authenticated-orcid":false,"given":"Lourdes","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-4079","authenticated-orcid":false,"given":"Luz","family":"Mart\u00edn-Carbonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-5211","authenticated-orcid":false,"given":"Ignacio","family":"De los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"De Matteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Ameigeiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8960-6622","authenticated-orcid":false,"given":"Marcela","family":"De Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Briz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda V.","family":"Preciado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-2213","authenticated-orcid":false,"given":"Amanda","family":"Fern\u00e1ndez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-2401","authenticated-orcid":false,"given":"Pamela","family":"Valva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncrna.2025.03.004_bib1","series-title":"Department of HIV\/AIDS","year":"2022"},{"issue":"Suppl 1","key":"10.1016\/j.ncrna.2025.03.004_bib2","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/jis926","article-title":"Pathogenesis of accelerated fibrosis in HIV\/HCV co-infection","volume":"207","author":"Lin","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ncrna.2025.03.004_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","article-title":"HIV\/hepatitis C coinfection natural history and disease progression","volume":"6","author":"Hernandez","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ncrna.2025.03.004_bib4","first-page":"304","article-title":"Liver fibrosis: causes and methods of assessment, A review","volume":"53","author":"Toosi","year":"2015","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.ncrna.2025.03.004_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0037-1601349","article-title":"Liver cancer emergence associated with antiviral treatment: an immune surveillance failure?","volume":"37","author":"Reig","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ncrna.2025.03.004_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mam.2017.11.001","article-title":"Extracellular vesicles: novel mediator for cell to cell communications in liver pathogenesis","volume":"60","author":"Devhare","year":"2018","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ncrna.2025.03.004_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.782485","article-title":"The role of exosomes in viral hepatitis and its associated liver diseases","volume":"8","author":"Zhou","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ncrna.2025.03.004_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jcp.30908","article-title":"MicroRNAs: small molecules with big impacts in liver injury","volume":"238","author":"Abdel Halim","year":"2023","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173507","article-title":"MicroRNA interplay between hepatic stellate cell quiescence and activation","volume":"885","author":"Ezhilarasan","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2021.01.008","article-title":"Circulating microRNAs: biomarkers of disease","volume":"516","author":"Wu","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ncrna.2025.03.004_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.ncrna.2025.03.004_bib12","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00109-023-02367-8","article-title":"MicroRNA signature from extracellular vesicles of HCV\/HIV co-infected individuals differs from HCV mono-infected","volume":"101","author":"Cairoli","year":"2023","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ncrna.2025.03.004_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12859-016-0994-9","article-title":"Sample size calculation while controlling false discovery rate for differential expression analysis with RNA-sequencing experiments","volume":"17","author":"Bi","year":"2016","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ncrna.2025.03.004_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000533595","article-title":"New potential MicroRNA biomarkers in human immunodeficiency virus elite controllers, human immunodeficiency virus infections, and coinfections with hepatitis B virus or hepatitis C virus","volume":"66","author":"Mahmud Hussen","year":"2023","journal-title":"Intervirology"},{"key":"10.1016\/j.ncrna.2025.03.004_bib15","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.4103\/jfmpc.jfmpc_666_21","article-title":"APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection","volume":"10","author":"Rungta","year":"2021","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.ncrna.2025.03.004_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"Electronic address eee, Clinical Practice Guideline P, Chair, representative EGB, Panel m. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib17","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","article-title":"Non-invasive diagnosis of liver fibrosis and cirrhosis","volume":"21","author":"Lurie","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib18","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1136\/gutjnl-2017-315846","article-title":"Liquid biopsy for liver diseases","volume":"67","author":"Mann","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ncrna.2025.03.004_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fphar.2017.00056","article-title":"Circulating ECV-associated miRNAs as potential clinical biomarkers in early stage HBV and HCV induced liver fibrosis","volume":"8","author":"Lambrecht","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-015-0623-9","article-title":"Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis","volume":"13","author":"Momen-Heravi","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ncrna.2025.03.004_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphys.2012.00049","article-title":"microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis","volume":"3","author":"Noetel","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cells8040374","article-title":"Chronic hepatitis C virus infection impairs M1 macrophage differentiation and contributes to CD8(+) T-cell dysfunction","volume":"8","author":"Ahmed","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ncrna.2025.03.004_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","article-title":"miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis","volume":"50","author":"Guo","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib25","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.3748\/wjg.v25.i31.4468","article-title":"MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2","volume":"25","author":"Wu","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030277","article-title":"Extracellular vesicles as delivery vehicles for non-coding RNAs: potential biomarkers for chronic liver diseases","volume":"14","author":"Ferro","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ncrna.2025.03.004_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.ncrna.2025.03.004_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gendis.2015.01.001","article-title":"MicroRNAs: role in hepatitis C virus pathogenesis","volume":"2","author":"Shrivastava","year":"2015","journal-title":"Genes Dis"},{"key":"10.1016\/j.ncrna.2025.03.004_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104355","article-title":"The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV\/HCV, HIV\/HBV Co-infection and elite controllers for determination of biomarker","volume":"147","author":"Yousefpouran","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ncrna.2025.03.004_bib30","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.3390\/v4112485","article-title":"MicroRNAs, hepatitis C virus, and HCV\/HIV-1 co-infection: new insights in pathogenesis and therapy","volume":"4","author":"Gupta","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ncrna.2025.03.004_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2217\/bmm.12.107","article-title":"Circulating miR-122 as a potential biomarker of liver disease","volume":"7","author":"Laterza","year":"2013","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.ncrna.2025.03.004_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105192","article-title":"A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2025.03.004_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clinre.2016.10.013","article-title":"Evaluation of a combinational use of serum microRNAs as biomarkers for liver diseases","volume":"41","author":"Xu","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.ncrna.2025.03.004_bib34","first-page":"1428","article-title":"Circulating microRNA-122 as a potential biomarker for liver injury","volume":"5","author":"Ding","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ncrna.2025.03.004_bib35","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/liv.12627","article-title":"Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases","volume":"35","author":"Roderburg","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.ncrna.2025.03.004_bib36","article-title":"The miR-17-92 cluster: yin and Yang in human cancers","volume":"33","author":"Zhao","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.ncrna.2025.03.004_bib37","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.2174\/1381612827666210612054156","article-title":"MiR-92a-3p promotes the malignant progression of hepatocellular carcinoma by mediating the PI3K\/AKT\/mTOR signaling pathway","volume":"27","author":"Wang","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ncrna.2025.03.004_bib38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.22749","article-title":"Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma","volume":"49","author":"Ura","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ncrna.2025.03.004_bib39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tranon.2017.12.012","article-title":"Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer","volume":"11","author":"Fu","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ncrna.2025.03.004_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520981547","article-title":"Expression and clinical significance of miR-3615 in hepatocellular carcinoma","volume":"49","author":"Yuan","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ncrna.2025.03.004_bib41","doi-asserted-by":"crossref","first-page":"8534","DOI":"10.1038\/srep08534","article-title":"Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma","volume":"5","author":"Yu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ncrna.2025.03.004_bib42","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.5114\/aoms.2020.97967","article-title":"Differential expression of angiogenesis-related miRNAs and VEGFA in cirrhosis and hepatocellular carcinoma","volume":"16","author":"de Oliveira","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ncrna.2025.03.004_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.736677","article-title":"Analysis of miRNAs profiles in serum of patients with steatosis and steatohepatitis","volume":"9","author":"Vulf","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ncrna.2025.03.004_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040690","article-title":"Reinfection of transplanted livers in HCV- and HCV\/HIV-infected patients is characterized by a different MicroRNA expression profile","volume":"11","author":"Dalla","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ncrna.2025.03.004_bib45","article-title":"Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL\/NASH: impact of LPS\/TLR-4\/FoxO3 pathway","volume":"357","author":"Samy","year":"2024","journal-title":"Arch. Pharm. (Weinh.)"},{"key":"10.1016\/j.ncrna.2025.03.004_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112405","article-title":"HCV eradication with DAAs differently affects HIV males and females: a whole miRNA sequencing characterization","volume":"145","author":"Valle-Millares","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ncrna.2025.03.004_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jhg.2016.87","article-title":"MicroRNAs in extracellular vesicles: potential cancer biomarkers","volume":"62","author":"Kinoshita","year":"2017","journal-title":"J. Hum. Genet."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:55:44Z","timestamp":1778892944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054025000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S2468054025000332"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.03.004","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles derived microRNAs as non-invasive markers of liver fibrosis in chronically infected HCV patients: a pilot study","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}